济南怎么样治疗泌尿疾病济南看男科哪里好,济南精囊炎的早泄治疗,济南看男科的医院,济南男人硬度不够挂什么科,济南生殖健康咨询,济南感觉硬度不够,济南射精太快性生活时间短怎么办

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

BEIJING, July 17 (Xinhua) -- Iraqi Prime Minister Nouri al-Maliki arrived in Beijing Sunday night for his first official visit to China as a guest of his Chinese counterpart Wen Jiabao.During al-Maliki's stay in China from Sunday to Thursday, President Hu Jintao will meet with him, and Premier Wen will hold talks with the Iraqi prime minister, Chinese Foreign Ministry spokesman Hong Lei said earlier.China and Iraq share a traditional friendship, Hong said, adding that the two countries have witnessed smooth development of bilateral relations, steadily growing economic cooperation and increasing cultural exchanges."China is ready to work with the international community and to continue to provide assistance for the Iraqi people to improve their livelihoods," said the spokesman.

HOHHOT, July 8 (Xinhua) -- The 3rd Happy Grassland Fitness Day will kick off 16 August in Chifeng city, north China's Inner Mongolia Autonomous Region.12 cities and leagues in the region will send athletes to compete in 4 sports including Mongolian wrestling, Mongolian archery, table tennis and badminton.The activity was jointly held by the regional sports department and Chifeng sports department.